These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31517456)

  • 1. Effects of CHADS2 score, echocardiographic and haematologic parameters on stroke severity and prognosis in patients with stroke due to nonvalvular atrial fibrillation.
    Aynaci O; Tekataş A; Aynaci G; Kehaya S; Utku U
    Ideggyogy Sz; 2019 Jul; 72(7-8):241-256. PubMed ID: 31517456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CHADS
    Kondo T; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Heart Vessels; 2017 Feb; 32(2):193-200. PubMed ID: 27325225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
    Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
    Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.
    Morillas P; Pallarés V; Fácila L; Llisterri JL; Sebastián ME; Gómez M; Castilla E; Camarasa R; Sandin M; García-Honrubia A;
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):485-91. PubMed ID: 25487320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide in acute ischemic stroke.
    Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
    Rietbrock S; Heeley E; Plumb J; van Staa T
    Am Heart J; 2008 Jul; 156(1):57-64. PubMed ID: 18585497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
    Tokunaga K; Yamagami H; Koga M; Todo K; Kimura K; Itabashi R; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Kitazono T; Kinoshita N; Takasugi J; Okata T; Yoshimura S; Sato S; Arihiro S; Toyoda K;
    Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year clinical prediction in Chinese ischemic stroke patients using the CHADS2 and CHA2DS2-VASc scores: the China National Stroke Registry.
    Li SY; Zhao XQ; Wang CX; Liu LP; Liu GF; Wang YL; Wang YJ
    CNS Neurosci Ther; 2012 Dec; 18(12):988-93. PubMed ID: 23121837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of CHADS2 score on late stroke after the Cox maze procedure.
    Pet M; Robertson JO; Bailey M; Guthrie TJ; Moon MR; Lawton JS; Rinne A; Damiano RJ; Maniar HS
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):85-9. PubMed ID: 22818126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
    Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
    Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
    J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CHADS2 Components Are Associated with Stroke-Related In-hospital Mortality in Patients with Atrial Fibrillation.
    Yaghi S; Sherzai A; Pilot M; Sherzai D; Elkind MS
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2404-7. PubMed ID: 26231476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of CHADS
    Zhou X; Cao K; Kou S; Qu S; Li H; Yu Y; Wang C; Liu Y; Li P; Li D
    Int J Cardiol; 2017 Feb; 228():906-911. PubMed ID: 27912198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
    Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
    Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.